| 1 |
35250480 | Impaired Glucose Homeostasis in a Tau Knock-In Mouse Model. | 2022 |
3 |
| 2 |
35257729 | The role of non-enzymatic glycation on Tau-DNA interactions: Kinetic and mechanistic approaches. | 2022 May 15 |
2 |
| 3 |
33797777 | Combination of human tau and islet amyloid polypeptide exacerbates metabolic dysfunction in transgenic mice. | 2021 Jul |
2 |
| 4 |
34414533 | Generation and Role of Calpain-Cleaved 17-kDa Tau Fragment in Acute Ischemic Stroke. | 2021 Nov |
1 |
| 5 |
34649422 | Dynamic-Inspired Perspective on the Molecular Inhibitor of Tau Aggregation by Glucose Gallates Based on Human Neurons. | 2021 Nov 3 |
1 |
| 6 |
33147571 | Plasma tau predicts cerebral vulnerability in aging. | 2020 Nov 4 |
2 |
| 7 |
33282871 | Sphingolipids and Inositol Phosphates Regulate the Tau Protein Phosphorylation Status in Humanized Yeast. | 2020 |
1 |
| 8 |
31370885 | Late-stage Anle138b treatment ameliorates tau pathology and metabolic decline in a mouse model of human Alzheimer's disease tau. | 2019 Aug 1 |
2 |
| 9 |
30056470 | Dihydrolipoamide dehydrogenase suppression induces human tau phosphorylation by increasing whole body glucose levels in a C. elegans model of Alzheimer's Disease. | 2018 Nov |
1 |
| 10 |
27626216 | The Triangle of Death in Alzheimer's Disease Brain: The Aberrant Cross-Talk Among Energy Metabolism, Mammalian Target of Rapamycin Signaling, and Protein Homeostasis Revealed by Redox Proteomics. | 2017 Mar 10 |
1 |
| 11 |
28269785 | The Link between Type 2 Diabetes and Neurodegeneration: Roles for Amyloid-β, Amylin, and Tau Proteins. | 2017 |
1 |
| 12 |
28946565 | Alzheimer's Disease as the Product of a Progressive Energy Deficiency Syndrome in the Central Nervous System: The Neuroenergetic Hypothesis. | 2017 |
1 |
| 13 |
25646706 | Functional correlates of t-Tau, p-Tau and Aβ₁₋₄₂ amyloid cerebrospinal fluid levels in Alzheimer's disease: a ¹⁸F-FDG PET/CT study. | 2015 May |
2 |
| 14 |
26219917 | Glucose deprivation increases tau phosphorylation via P38 mitogen-activated protein kinase. | 2015 Dec |
1 |
| 15 |
23254634 | Hyperglycemia-induced tau cleavage in vitro and in vivo: a possible link between diabetes and Alzheimer's disease. | 2013 |
3 |
| 16 |
21295279 | Functional screening of Alzheimer pathology genome-wide association signals in Drosophila. | 2011 Feb 11 |
1 |
| 17 |
20450234 | Targeting tau protein in Alzheimer's disease. | 2010 May |
1 |
| 18 |
19659459 | Brain glucose transporters, O-GlcNAcylation and phosphorylation of tau in diabetes and Alzheimer's disease. | 2009 Oct |
1 |
| 19 |
18174027 | Decreased glucose transporters correlate to abnormal hyperphosphorylation of tau in Alzheimer disease. | 2008 Jan 23 |
1 |
| 20 |
18395614 | CSF phosporylated TAU protein levels correlate with cerebral glucose metabolism assessed with PET in Alzheimer's disease. | 2008 May 15 |
1 |
| 21 |
17898350 | Association of the tau haplotype H2 with age at onset and functional alterations of glucose utilization in frontotemporal dementia. | 2007 Oct |
2 |
| 22 |
17053872 | Alois Alzheimer revisited: differences in origin of the disease carrying his name. | 2006 Nov |
1 |
| 23 |
15249677 | O-GlcNAcylation regulates phosphorylation of tau: a mechanism involved in Alzheimer's disease. | 2004 Jul 20 |
1 |
| 24 |
15312816 | Association of elevated phospho-tau levels with Alzheimer-typical 18F-fluoro-2-deoxy-D-glucose positron emission tomography findings in patients with mild cognitive impairment. | 2004 Aug 15 |
1 |
| 25 |
11113614 | Brain glucose and energy metabolism abnormalities in sporadic Alzheimer disease. Causes and consequences: an update. | 2000 Dec |
1 |
| 26 |
9846894 | Modification of tau to an Alzheimer's type protein interferes with its interaction with microtubules. | 1998 Nov |
1 |
| 27 |
9062894 | Immunological characterization of epitopes on tau of Alzheimer's type and chemically modified tau. | 1997 Mar |
1 |
| 28 |
7545739 | Tau protein concentrations in cerebrospinal fluid of patients with dementia of the Alzheimer type. | 1995 Sep |
1 |